Clinical trial

Rifabutin Based Therapy for the Eradication of Staphylococcus Aureus Colonization in HIV Infected Adults

NCT00869518

Study summary

ClinicalTrials.gov

Rifabutin Based Therapy for the Eradication of Staphylococcus Aureus Colonization in HIV Infected Adults

Design: INTERVENTIONAL · Status: TERMINATED · Phase: PHASE2

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DRUG · Unmapped registry intervention rifabutin plus trimethoprim sulfamethoxazole Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention placebo plus trimethoprim-sulfamethoxazole Find medicine records · Find other trials using this name

StatusTERMINATED

Study typeINTERVENTIONAL

Start date2009-07-01

PhasePHASE2

Conditions

Staphylococcus Aureusunresolved

HIV Infectionsunresolved

Interventions

rifabutin plus trimethoprim sulfamethoxazoleDRUG

placebo plus trimethoprim-sulfamethoxazoleDRUG

Sponsors & collaborators

University of California, San Franciscolead sponsor

Mapped research locations

San FranciscoCalifornia, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00869518 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.